The average one-year price target for Helius Medical Technologies (NasdaqCM:HSDT) has been revised to 15.78 / share. This is an decrease of 9.73% from the prior estimate of 17.48 dated March 28, 2024.
Some results have been hidden because they may be inaccessible to you